| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 14:06 | Xtrackers ETC issues new tranche of gold-backed securities | ||
| 14:06 | Needham raises Lumentum stock price target to $550 on AI demand | ||
| 14:06 | H.C. Wainwright reiterates Buy rating on Invivyd stock amid FDA feedback | ||
| 14:06 | Needham raises Benchmark stock price target to $62 on strong Q4 results | ||
| 14:06 | AMD stock price target lowered to $275 by Mizuho on higher expenses | ||
| 14:06 | Needham lowers Varonis Systems stock price target to $30 on SaaS transition concerns | ||
| 14:06 | International Seaways stock price target raised to $70 by BTIG on strong tanker rates | ||
| 14:06 | Mizuho raises Ball Corp stock price target to $70 on strong earnings | ||
| 14:06 | Exelixis stock maintains Buy rating at H.C. Wainwright on FDA review news | ||
| 14:06 | Mizuho raises Enphase Energy stock price target to $39 on new products | ||
| 14:06 | AMD stock rating reiterated at Outperform by Northland on strong AI momentum | ||
| 13:55 | B.Riley reiterates Buy rating on Journey Medical stock, maintains $12 target | ||
| 13:55 | B.Riley reiterates Buy rating on Verastem stock, maintains $16 target | ||
| 13:55 | Mizuho raises Willis Towers Watson stock price target on strong growth outlook | ||
| 13:55 | Cytokinetics stock maintains Buy rating at B.Riley amid strong CMI market | ||
| 13:55 | Madrigal Pharmaceuticals stock maintains Buy rating at B.Riley on strong Rezdiffra growth | ||
| 13:55 | Take-Two Interactive stock outperforms as Oppenheimer maintains $265 target | ||
| 13:54 | EVTV advances data center initiative with AZIO AI after site validation | ||
| 13:54 | DXP Enterprises acquires Ambiente H2O to expand water services | ||
| 13:54 | Mobix Labs secures FAA certification for drone inspection platform | ||
| 13:54 | BetMGM reports record year with $2.8 billion in revenue, turns profitable | ||
| 13:54 | Equinor Q4 2025 slides: Record production drives strong cash flow amid strategic shifts | ||
| 13:54 | Xtrackers ETC issues new tranche of physical silver EUR hedged securities | ||
| 13:54 | Verastem reports $17.5 million in Q4 revenue for cancer treatment | ||
| 13:54 | High-dose nusinersen shows improved outcomes in spinal muscular atrophy |